0001144204-15-012374.txt : 20150227
0001144204-15-012374.hdr.sgml : 20150226
20150226210027
ACCESSION NUMBER: 0001144204-15-012374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150224
FILED AS OF DATE: 20150226
DATE AS OF CHANGE: 20150226
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001270073
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223868459
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 646-747-1000
MAIL ADDRESS:
STREET 1: 450 W. 15TH STREET
STREET 2: SUITE 505
CITY: New York
STATE: NY
ZIP: 10011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VEITINGER KLAUS R DR
CENTRAL INDEX KEY: 0001283972
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35668
FILM NUMBER: 15654734
4
1
v403052_4.xml
OWNERSHIP DOCUMENT
X0306
4
2015-02-24
0
0001270073
INTERCEPT PHARMACEUTICALS INC
ICPT
0001283972
VEITINGER KLAUS R DR
C/O INTERCEPT PHARMACEUTICALS, INC.
450 W. 15TH STREET, SUITE 505
NEW YORK
NY
10011
1
0
0
0
Common Stock
2015-02-24
4
M
0
632
21.5
A
2798
D
Common Stock
2015-02-24
4
S
0
632
222.50
D
2166
D
Options to Purchase Common Stock
21.5
2015-02-24
4
M
0
632
0
D
2022-11-16
Common Stock
632
9536
D
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 13, 2014.
All shares underlying this option have vested.
/s/ Bryan Yoon, as attorney-in-fact
2015-02-26